Essential Things to Know Before Prescribing Symbicort: A Comprehensive Guide to Symbicort Prescribing Information
Symbicort is a prescription medication that is widely used to manage symptoms of asthma and chronic obstructive pulmonary disease (COPD). It contains a combination of budesonide (a corticosteroid) and formoterol (a long-acting beta-agonist), which work together to reduce inflammation and improve breathing.
If you are a healthcare professional who is considering prescribing Symbicort for your patients, there are several important things that you should keep in mind. In this comprehensive guide, we will take a closer look at some of the essential information you need to know before prescribing Symbicort.
Indications and Usage
Before prescribing Symbicort, it is important to understand the indications and usage of the medication. Symbicort is indicated for the treatment of asthma in patients aged 6 years and older who require a combination of an inhaled corticosteroid and a long-acting beta-agonist. It is also indicated for the maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD.
Dosage and Administration
The dosage of Symbicort will depend on several factors, including the patient’s age, weight, severity of asthma or COPD, and previous asthma therapy. The recommended starting dose for most patients is two inhalations of Symbicort 160/4.5 mcg twice daily. The maximum recommended dose is two inhalations of Symbicort 320/9 mcg twice daily.
It is important to note that Symbicort should be used regularly for optimal benefit. Patients should also be instructed to rinse their mouth with water after each use to prevent thrush.
Precautions and Warnings
Symbicort is contraindicated in patients with a history of hypersensitivity to budesonide or formoterol. It should also not be used for the relief of acute bronchospasm. Symbicort should be used with caution in patients with cardiovascular disorders, diabetes, or hyperthyroidism.
Additionally, Symbicort may increase the risk of pneumonia in patients with COPD. Patients should be carefully monitored for signs and symptoms of pneumonia, including fever, chills, and cough.
Drug Interactions
Symbicort may interact with other medications, including beta-blockers, diuretics, and MAO inhibitors. Be sure to review the patient’s complete medication list before prescribing Symbicort to avoid potential drug interactions.
Conclusion
In conclusion, Symbicort can be an effective treatment option for patients with asthma or COPD. Before prescribing Symbicort, be sure to understand the indications and usage, dosage and administration, precautions and warnings, and potential drug interactions. By following these essential guidelines, you can help ensure that your patients receive safe and effective treatment with Symbicort.
